ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SWKH SWK Holdings Corporation

15.80
0.00 (0.00%)
Pre Market
Last Updated: 10:40:37
Delayed by 15 minutes
Share Name Share Symbol Market Type
SWK Holdings Corporation NASDAQ:SWKH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 15.80 15.20 25.12 5 10:40:37

SWK Holdings Corporation to Report Third Quarter 2023 Financial Results

06/11/2023 9:05pm

PR Newswire (US)


SWK (NASDAQ:SWKH)
Historical Stock Chart


From Dec 2022 to Dec 2024

Click Here for more SWK Charts.

Conference Call and Live Audio Webcast Scheduled for Thursday, November 9, 2023, at 10:00 a.m. ET

DALLAS, Nov. 6, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced today that the Company will host a conference call and live audio webcast on Thursday, November 9, 2023, at 10:00 a.m. ET, to discuss its corporate and financial results for the third quarter of 2023.

SWK Holdings Corporation (PRNewsfoto/SWK Holdings Corporation)

Interested participants and investors may access the conference call by dialing either:

  • (844) 378-6488 (U.S.)
  • (412) 317-1079 (International)

An audio webcast will be accessible via the Investors Events & Presentations section of the SWK Holdings' website: https://swkhold.investorroom.com/events. An archive of the webcast will remain available for 90 days beginning at approximately 11:00 a.m. ET, on Nov. 9, 2023.

About SWK Holdings Corporation
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. SWK's unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million. SWK also owns Enteris BioPharma, a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence® platform. Additional information on the life science finance market is available on the Company's website at www.swkhold.com. 

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors which, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/swk-holdings-corporation-to-report-third-quarter-2023-financial-results-301978961.html

SOURCE SWK Holdings Corporation

Copyright 2023 PR Newswire

1 Year SWK Chart

1 Year SWK Chart

1 Month SWK Chart

1 Month SWK Chart

Your Recent History

Delayed Upgrade Clock